Sangamo Therapeutics
SGMO
$0.52
Share price
2.94%
Change (1 day)
-67.84%
Change (1 year)
Sangamo Therapeutics (SGMO) - Total assets
Total assets on the balance sheet as of December 2023 : $0.16 B
According to Sangamo Therapeutics 's latest financial reports the company's total assets are $0.16 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Sangamo Therapeutics - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.16 B | -70.61% |
| 2022-12-31 | $0.56 B | -22.08% |
| 2021-12-31 | $0.72 B | -23.08% |
| 2020-12-31 | $0.93 B | 47.22% |
| 2019-12-31 | $0.63 B | 7.98% |
| 2018-12-31 | $0.59 B | 105.9% |
| 2017-12-31 | $0.28 B | 81.61% |
| 2016-12-31 | $0.15 B | -27.32% |
| 2015-12-31 | $0.21 B | -10.68% |
| 2014-12-31 | $0.24 B | 72.69% |
| 2013-12-31 | $0.14 B | 70.64% |
| 2012-12-31 | $82.53 M | -5.5% |
| 2011-12-31 | $87.33 M | 38.63% |
| 2010-12-31 | $62.99 M | -27.95% |
| 2009-12-31 | $87.43 M | 28.87% |
| 2008-12-31 | $67.85 M | -19.13% |
| 2007-12-31 | $83.9 M | 50.41% |
| 2006-12-31 | $55.78 M | 13.88% |
| 2005-12-31 | $48.98 M | 41.06% |
| 2004-12-31 | $34.72 M | -24.89% |
| 2003-12-31 | $46.23 M | -17.78% |
| 2002-12-31 | $56.22 M | -33.86% |
| 2001-12-31 | $85.01 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $167.55 B | 101,253.74% | 🇺🇸 USA |
 Amgen AMGN | $97.15 B | 58,667.24% | 🇺🇸 USA |
 Biogen BIIB | $26.84 B | 16,138.08% | 🇺🇸 USA |
 Dow DOW | $57.96 B | 34,963.51% | 🇺🇸 USA |
 Gilead Sciences GILD | $62.12 B | 37,478.64% | 🇺🇸 USA |
 Merck MRK | $106.67 B | 64,426.37% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $3.82 B | 2,216.65% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $6.84 B | 4,038.40% | 🇺🇸 USA |